Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2011

Open Access 01-02-2011 | Research article

Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta

Authors: Catherine Baugé, Olivier Cauvard, Sylvain Leclercq, Philippe Galéra, Karim Boumédiene

Published in: Arthritis Research & Therapy | Issue 1/2011

Login to get access

Abstract

Introduction

Transforming growth factor beta (TGFβ) plays a central role in morphogenesis, growth, and cell differentiation. This cytokine is particularly important in cartilage where it regulates cell proliferation and extracellular matrix synthesis. While the action of TGFβ on chondrocyte metabolism has been extensively catalogued, the modulation of specific genes that function as mediators of TGFβ signalling is poorly defined. In the current study, elements of the Smad component of the TGFβ intracellular signalling system and TGFβ receptors were characterised in human chondrocytes upon TGFβ1 treatment.

Methods

Human articular chondrocytes were incubated with TGFβ1. Then, mRNA and protein levels of TGFβ receptors and Smads were analysed by RT-PCR and western blot analysis. The role of specific protein 1 (Sp1) was investigated by gain and loss of function (inhibitor, siRNA, expression vector).

Results

We showed that TGFβ1 regulates mRNA levels of its own receptors, and of Smad3 and Smad7. It modulates TGFβ receptors post-transcriptionally by affecting their mRNA stability, but does not change the Smad-3 and Smad-7 mRNA half-life span, suggesting a potential transcriptional effect on these genes. Moreover, the transcriptional factor Sp1, which is downregulated by TGFβ1, is involved in the repression of both TGFβ receptors but not in the modulation of Smad3 and Smad7. Interestingly, Sp1 ectopic expression permitted also to maintain a similar expression pattern to early response to TGFβ at 24 hours of treatment. It restored the induction of Sox9 and COL2A1 and blocked the late response (repression of aggrecan, induction of COL1A1 and COL10A1).

Conclusions

These data help to better understand the negative feedback loop in the TGFβ signalling system, and enlighten an interesting role of Sp1 to regulate TGFβ response.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pujol JP, Chadjichristos C, Legendre F, Baugé C, Beauchef G, Andriamanalijaona R, Galéra P, Boumediene K: Interleukin-1 and transforming growth factor β1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res. 2008, 49: 293-297. 10.1080/03008200802148355.CrossRef Pujol JP, Chadjichristos C, Legendre F, Baugé C, Beauchef G, Andriamanalijaona R, Galéra P, Boumediene K: Interleukin-1 and transforming growth factor β1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res. 2008, 49: 293-297. 10.1080/03008200802148355.CrossRef
2.
go back to reference Docagne F, Gabriel C, Lebeurrier N, Lesné S, Hommet Y, Plawinski L, Mackenzie ET, Vivien D: Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. Biochem J. 2004, 383: 393-399. 10.1042/BJ20040682.CrossRef Docagne F, Gabriel C, Lebeurrier N, Lesné S, Hommet Y, Plawinski L, Mackenzie ET, Vivien D: Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. Biochem J. 2004, 383: 393-399. 10.1042/BJ20040682.CrossRef
3.
go back to reference Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V: Smad-Sp1 complexes mediate TGFβ-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis. 2006, 27: 2392-2401. 10.1093/carcin/bgl078.CrossRef Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, Ellenrieder V: Smad-Sp1 complexes mediate TGFβ-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis. 2006, 27: 2392-2401. 10.1093/carcin/bgl078.CrossRef
4.
go back to reference Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P: Identification of Smad7, a TGFβ-inducible antagonist of TGF-beta signalling. Nature. 1997, 389: 631-635. 10.1038/39369.CrossRef Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P: Identification of Smad7, a TGFβ-inducible antagonist of TGF-beta signalling. Nature. 1997, 389: 631-635. 10.1038/39369.CrossRef
5.
go back to reference van der Kraan PM, van den Berg WB: Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing. Ageing Res Rev. 2008, 7: 106-113. 10.1016/j.arr.2007.10.001.CrossRef van der Kraan PM, van den Berg WB: Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing. Ageing Res Rev. 2008, 7: 106-113. 10.1016/j.arr.2007.10.001.CrossRef
6.
go back to reference Yang X, Chen L, Xu X, Li C, Huang C, Deng CX: TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol. 2001, 153: 35-46. 10.1083/jcb.153.1.35.CrossRef Yang X, Chen L, Xu X, Li C, Huang C, Deng CX: TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol. 2001, 153: 35-46. 10.1083/jcb.153.1.35.CrossRef
7.
go back to reference Yao JY, Wang Y, An J, Mao CM, Hou N, Lv YX, Wang YL, Cui F, Huang M, Yang X: Mutation analysis of the Smad3 gene in human osteoarthritis. Eur J Hum Genet. 2003, 11: 714-717. 10.1038/sj.ejhg.5201034.CrossRef Yao JY, Wang Y, An J, Mao CM, Hou N, Lv YX, Wang YL, Cui F, Huang M, Yang X: Mutation analysis of the Smad3 gene in human osteoarthritis. Eur J Hum Genet. 2003, 11: 714-717. 10.1038/sj.ejhg.5201034.CrossRef
8.
go back to reference Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL: Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol. 1997, 139: 541-552. 10.1083/jcb.139.2.541.CrossRef Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL: Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol. 1997, 139: 541-552. 10.1083/jcb.139.2.541.CrossRef
9.
go back to reference Boumediene K, Conrozier T, Mathieu P, Richard M, Marcelli C, Vignon E, Pujol JP: Decrease of cartilage transforming growth factor-beta receptor II expression in the rabbit experimental osteoarthritis - potential role in cartilage breakdown. Osteoarthritis Cartilage. 1998, 6: 146-149. 10.1053/joca.1997.0104.CrossRef Boumediene K, Conrozier T, Mathieu P, Richard M, Marcelli C, Vignon E, Pujol JP: Decrease of cartilage transforming growth factor-beta receptor II expression in the rabbit experimental osteoarthritis - potential role in cartilage breakdown. Osteoarthritis Cartilage. 1998, 6: 146-149. 10.1053/joca.1997.0104.CrossRef
10.
go back to reference Kaiser M, Haag J, Söder S, Bau B, Aigner T: Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1β. Arthritis Rheum. 2004, 50: 3535-3540. 10.1002/art.20750.CrossRef Kaiser M, Haag J, Söder S, Bau B, Aigner T: Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1β. Arthritis Rheum. 2004, 50: 3535-3540. 10.1002/art.20750.CrossRef
11.
go back to reference Porée B, Kypriotou M, Chadjichristos C, Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann DJ, Malléin-Gerin F, Pujol JP, Boumediene K, Galera P: Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem. 2008, 283: 4850-4865.CrossRef Porée B, Kypriotou M, Chadjichristos C, Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann DJ, Malléin-Gerin F, Pujol JP, Boumediene K, Galera P: Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem. 2008, 283: 4850-4865.CrossRef
12.
go back to reference Piera-Velazquez S, Hawkins DF, Whitecavage MK, Colter DC, Stokes DG, Jimenez SA: Regulation of the human SOX9 promoter by Sp1 and CREB. Exp Cell Res. 2007, 313: 1069-1079. 10.1016/j.yexcr.2007.01.001.CrossRef Piera-Velazquez S, Hawkins DF, Whitecavage MK, Colter DC, Stokes DG, Jimenez SA: Regulation of the human SOX9 promoter by Sp1 and CREB. Exp Cell Res. 2007, 313: 1069-1079. 10.1016/j.yexcr.2007.01.001.CrossRef
13.
go back to reference Baugé C, Beauchef G, Leclercq S, Kim SJ, Pujol JP, Galéra P, Boumédiene K: NFκB mediates IL-1β-induced down-regulation of TβRII through the modulation of Sp3 expression. J Cell Mol Med. 2008, 12: 1754-1766.CrossRef Baugé C, Beauchef G, Leclercq S, Kim SJ, Pujol JP, Galéra P, Boumédiene K: NFκB mediates IL-1β-induced down-regulation of TβRII through the modulation of Sp3 expression. J Cell Mol Med. 2008, 12: 1754-1766.CrossRef
14.
go back to reference Baugé C, Legendre F, Leclercq S, Elissalde JM, Pujol JP, Galéra P, Boumédiene K: Interleukin-1β impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum. 2007, 56: 3020-3032.CrossRef Baugé C, Legendre F, Leclercq S, Elissalde JM, Pujol JP, Galéra P, Boumédiene K: Interleukin-1β impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum. 2007, 56: 3020-3032.CrossRef
15.
go back to reference Roman-Blas JA, Stokes DG, Jimenez SA: Modulation of TGFβ signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage. 2007, 15: 1367-1377. 10.1016/j.joca.2007.04.011.CrossRef Roman-Blas JA, Stokes DG, Jimenez SA: Modulation of TGFβ signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage. 2007, 15: 1367-1377. 10.1016/j.joca.2007.04.011.CrossRef
16.
go back to reference Bloom BB, Humphries DE, Kuang PP, Fine A, Goldstein RH: Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim Biophys Acta. 1996, 1312: 243-248. 10.1016/0167-4889(96)00043-2.CrossRef Bloom BB, Humphries DE, Kuang PP, Fine A, Goldstein RH: Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: regulation by TGF-beta. Biochim Biophys Acta. 1996, 1312: 243-248. 10.1016/0167-4889(96)00043-2.CrossRef
17.
go back to reference Kim KK, Ji C, Chang W, Wells RG, Gundberg CM, McCarthy TL, Centrella M: Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts. Gene. 2006, 379: 175-184. 10.1016/j.gene.2006.05.005.CrossRef Kim KK, Ji C, Chang W, Wells RG, Gundberg CM, McCarthy TL, Centrella M: Repetitive exposure to TGF-beta suppresses TGF-beta type I receptor expression by differentiated osteoblasts. Gene. 2006, 379: 175-184. 10.1016/j.gene.2006.05.005.CrossRef
18.
go back to reference Centrella M, Ji C, Casinghino S, McCarthy TL: Rapid flux in transforming growth factor-beta receptors on bone cells. J Biol Chem. 1996, 271: 18616-18622. 10.1074/jbc.271.31.18616.CrossRef Centrella M, Ji C, Casinghino S, McCarthy TL: Rapid flux in transforming growth factor-beta receptors on bone cells. J Biol Chem. 1996, 271: 18616-18622. 10.1074/jbc.271.31.18616.CrossRef
19.
go back to reference Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol. 1987, 105: 965-975. 10.1083/jcb.105.2.965.CrossRef Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol. 1987, 105: 965-975. 10.1083/jcb.105.2.965.CrossRef
20.
go back to reference Massagué J, Like B: Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem. 1985, 260: 2636-2645.PubMed Massagué J, Like B: Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem. 1985, 260: 2636-2645.PubMed
21.
go back to reference Gebken J, Feydt A, Brinckmann J, Notbohm H, Müller PK, Bätge B: Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. J Endocrinol. 1999, 161: 503-510. 10.1677/joe.0.1610503.CrossRef Gebken J, Feydt A, Brinckmann J, Notbohm H, Müller PK, Bätge B: Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. J Endocrinol. 1999, 161: 503-510. 10.1677/joe.0.1610503.CrossRef
22.
go back to reference Mori Y, Chen SJ, Varga J: Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res. 2000, 258: 374-383. 10.1006/excr.2000.4930.CrossRef Mori Y, Chen SJ, Varga J: Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res. 2000, 258: 374-383. 10.1006/excr.2000.4930.CrossRef
23.
go back to reference Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, Takagi K, Takahashi T: Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene. 1998, 17: 1743-1747. 10.1038/sj.onc.1202052.CrossRef Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, Takagi K, Takahashi T: Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene. 1998, 17: 1743-1747. 10.1038/sj.onc.1202052.CrossRef
24.
go back to reference Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE: Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation. J Biol Chem. 2007, 282: 15534-15540. 10.1074/jbc.M701991200.CrossRef Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE: Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation. J Biol Chem. 2007, 282: 15534-15540. 10.1074/jbc.M701991200.CrossRef
25.
go back to reference Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG: Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 2007, 27: 4488-4499. 10.1128/MCB.01636-06.CrossRef Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG: Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol. 2007, 27: 4488-4499. 10.1128/MCB.01636-06.CrossRef
26.
go back to reference Qiao B, Padilla SR, Benya PD: Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J Biol Chem. 2005, 280: 17562-17571. 10.1074/jbc.M500646200.CrossRef Qiao B, Padilla SR, Benya PD: Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J Biol Chem. 2005, 280: 17562-17571. 10.1074/jbc.M500646200.CrossRef
27.
go back to reference Yu Z, Xing Y: All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Biochem Biophys Res Commun. 2006, 340: 929-934. 10.1016/j.bbrc.2005.12.100.CrossRef Yu Z, Xing Y: All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Biochem Biophys Res Commun. 2006, 340: 929-934. 10.1016/j.bbrc.2005.12.100.CrossRef
28.
go back to reference Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM: Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol. 2009, 182: 7937-7945. 10.4049/jimmunol.0803991.CrossRef Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM: Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol. 2009, 182: 7937-7945. 10.4049/jimmunol.0803991.CrossRef
29.
go back to reference Hellingman CA, Blaney Davidson E, Koevoet W, Vitters EL, van den Berg WB, van Osch G, van der Kraan PM: Smad signaling determines chondrogenic differentiation of bone-marrow derived mesenchymal stem cells: inhibition of Smad 1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A. 2010. Hellingman CA, Blaney Davidson E, Koevoet W, Vitters EL, van den Berg WB, van Osch G, van der Kraan PM: Smad signaling determines chondrogenic differentiation of bone-marrow derived mesenchymal stem cells: inhibition of Smad 1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A. 2010.
30.
go back to reference Chadjichristos C, Ghayor C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, Galéra P: Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-β1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem. 2002, 277: 43903-43917. 10.1074/jbc.M206111200.CrossRef Chadjichristos C, Ghayor C, Herrouin JF, Ala-Kokko L, Suske G, Pujol JP, Galéra P: Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-β1) in articular chondrocytes involves SP3/SP1 ratio. J Biol Chem. 2002, 277: 43903-43917. 10.1074/jbc.M206111200.CrossRef
31.
go back to reference Ghosh AK, Mori Y, Dowling E, Varga J: Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun. 2007, 354: 420-426. 10.1016/j.bbrc.2006.12.204.CrossRef Ghosh AK, Mori Y, Dowling E, Varga J: Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun. 2007, 354: 420-426. 10.1016/j.bbrc.2006.12.204.CrossRef
33.
go back to reference Sysa P, Potter JJ, Liu X, Mezey E: Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 2009, 28: 425-434. 10.1089/dna.2009.0884.CrossRef Sysa P, Potter JJ, Liu X, Mezey E: Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 2009, 28: 425-434. 10.1089/dna.2009.0884.CrossRef
34.
go back to reference Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K: Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Rheumatology (Oxford). 2006, 45: 157-165. 10.1093/rheumatology/kei124.CrossRef Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K: Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Rheumatology (Oxford). 2006, 45: 157-165. 10.1093/rheumatology/kei124.CrossRef
35.
go back to reference Poncelet AC, Schnaper HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001, 276: 6983-6992. 10.1074/jbc.M006442200.CrossRef Poncelet AC, Schnaper HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001, 276: 6983-6992. 10.1074/jbc.M006442200.CrossRef
36.
go back to reference Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG: Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene. 2000, 19: 4660-4667. 10.1038/sj.onc.1203822.CrossRef Periyasamy S, Ammanamanchi S, Tillekeratne MP, Brattain MG: Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene. 2000, 19: 4660-4667. 10.1038/sj.onc.1203822.CrossRef
37.
go back to reference Jennings R, Alsarraj M, Wright KL, Muñoz-Antonia T: Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites. Oncogene. 2001, 20: 6899-6909. 10.1038/sj.onc.1204808.CrossRef Jennings R, Alsarraj M, Wright KL, Muñoz-Antonia T: Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites. Oncogene. 2001, 20: 6899-6909. 10.1038/sj.onc.1204808.CrossRef
Metadata
Title
Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta
Authors
Catherine Baugé
Olivier Cauvard
Sylvain Leclercq
Philippe Galéra
Karim Boumédiene
Publication date
01-02-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3247

Other articles of this Issue 1/2011

Arthritis Research & Therapy 1/2011 Go to the issue